Sign inJoin waitlistJoin the waitlist

DK

David Kaslow

FDA · University of Washington School of Medicine

Credentials: · ·

History

University of Washington School of Medicine
Present

Research

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
The Journal of Infectious Diseases · 1998 · 198 citations
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
The Journal of Infectious Diseases · 2016 · 187 citations
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015
Vaccine · 2016 · 174 citations

JK
Jerome Kim
7 papers
BL
Bhavna Lall
5 papers
CB
Chris Van Beneden
5 papers
Joseph Vinetz
5 papers
Shmuel Shoham
5 papers
KM
Kayvon Modjarrad
4 papers
Ruth Karron
4 papers
Anna Durbin
3 papers
Carol Baker
3 papers
CO
Christian Ockenhouse
3 papers
Jeffrey Cannon
3 papers · 3 as a resident
AM
Alan Magill
2 papers